Xia Li

Xia Li

Auto-generated profile, based on publicly available information

Xia Li

Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2024 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
SZShiying Zhang
Shiying Zhang
XLXia Li
Xia Li
YLYang Liu
Yang Liu
HLHui Li
Hui Li
Zhiyue ZhangZhiyue Zhang
Zhiyue Zhang
Lung cancer remains a leading cause of cancer-related deaths globally, and a significant number of patients are ineligible for surgery, while chemoradiotherapy often shows limited efficacy, a systemic distribution, a low drug concentration at tumor sites, severe side effects, and the emergence of drug resistance. In this context, a nanodrug delivery system (NDDS) has emerged as a promising approach for lung cancer treatment, offering distinct advantages such as targeted delivery, responsiveness to the tumor microenvironment, site-specific release, and enhanced induction of apoptosis in cancer cells, ultimately leading to tumor growth inhibition or even elimination. This review aims to provide an overview of the physiological characteristics of lung cancer, highlight the limitations of conventional treatment methods, and extensively examine recent significant advancements in NDDS utilized for lung cancer therapy. The findings from this review lay the foundation for further development and optimization of NDDSs in the treatment of lung cancer.

1 August 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
YHYanyun Hao
Yanyun Hao
HLHui Li
Hui Li
XGXiaoyan Ge
Xiaoyan Ge
YLYang Liu
Yang Liu
JYJialin Yin
Jialin Yin
Zhiyue ZhangZhiyue Zhang
Zhiyue Zhang